Yael Brenner, VP Quality at Kamada Ltd, filed a Form 4 on September 8, 2026, disclosing a net exercise of employee stock options in ordinary shares on September 2, 2026.
Aktis Oncology (NASDAQ:AKTS) shares are sliding sharply as the stock gives back recent gains, trading down after touching a high near $26.99 earlier in the session onVolumeroughly in line with average. Aktis Oncology is a clinical-stage biotechnology company focused on developing targetedAlpharadiopharmaceutical therapies to …
A NASDAQ-listed biotechnology company is trading sharply lower today, on pace for one of its worst single-day losses since 2001, despite announcing landmark survival data for one of its cancer therapies, an outcome that would typically be read as good news for the stock. …
A Form 4 filed on September 8, 2026 by David Tsur, a director of Kamada Ltd (NASDAQ:KMDA), discloses the net exercise of two employee stock option grants covering a combined 49,000 ordinary shares on September 2, 2026.
Elie Melhem, President of APAC, Middle East, and Africa at Watts Water Technologies Inc, filed a Form 4 on September 8, 2026, disclosing the sale of 1,096 shares of Class A Common Stock on September 4, 2026.
Liu Chitung, CFO and Senior Vice President of United Microelectronics Corp, filed a Form 4 on September 8, 2026, disclosing a change in the form of beneficial ownership of Common Shares resulting from the expiration and termination of a CTBC Bank Trust on September …
A Form 4 filed with the SEC on September 8, 2026, discloses that Andrew Macdonald, President and Chief Operating Officer of Uber Technologies, Inc. (NYSE:UBER), purchased a total of 70,000 shares of common stock on September 4, 2026.
Deanna D. Strable-Soethout, Chair, President and CEO of Principal Financial Group Inc., filed a Form 4 on September 8, 2026, reporting stock option exercises and a sale of common shares transacted on September 3, 2026, under a pre-established Rule 10b5-1 trading plan.
A Form 4 filed on September 8, 2026 with the SEC discloses that Daniel P. Donlan, CFO and Treasurer of NETSTREIT Corp. (NYSE:NTST), acquired 1,200 shares of common stock on September 4, 2026 at a weighted-average price of $20.12 per share.
Kura Oncology, Inc. filed a current report on September 8, 2026, disclosing the appointment of Jennifer Fulk as Chief Financial Officer, principal financial officer, and principal accounting officer, effective that same date.